Most Read Articles
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
11 Aug 2019
Treatment with low-to-standard dose dual combination therapy of blood pressure (BP)-lowering drugs is more effective than standard-dose monotherapy and does not increase withdrawals due to adverse events, a recent study has shown.
20 Jun 2019
Untreated white coat hypertension (WCH), but not treated white coat effect (WCE), may increase the risk for cardiovascular events and all-cause mortality, suggest the results of a systematic review and meta-analysis. Out-of-office blood pressure (BP) monitoring is thus important in the diagnosis and management of hypertension.
06 Aug 2019
Risk factors for 1-year mortality in heart failure (HF) patients significantly differ between those with and without chronic kidney disease (CKD), especially with regard to the use of beta-blockers or diuretics at discharge, according to a study. This suggests that these patients may benefit from individualized therapies.

Predictors of cardiac mortality in PCI-treated STEMI patients

Tristan Manalac
20 Jul 2019

In patients with ST-segment elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PPCI), admission Killip classification and creatinine and troponin levels are important cardiac mortality predictors, according to a recent Singapore study.

Using a real-world acute myocardial infarction registry, the present study has “provided the variables and their associated scores that could be incorporated into a risk score to risk-stratify patients and guide duration of hospital stay, short- and medium-term management and follow-up, to improve outcomes in these patients,” said researchers.

Drawing from the Singapore Myocardial Infarction Registry, researchers identified 11,546 STEMI patients who received PPCI. The overall mortality rate was 6.4 percent and the corresponding 30-day and 1-year values were 6.8 percent and 8.3 percent. Majority of the participants (70 percent; n=8,082; median age, 57.6 years; 85.2 percent male) were assigned to the derivation cohort. [Sci Rep 2019;9:10072]

Multivariable logistic regression analysis in the validation cohort identified older age as a significant risk factor for in-hospital (80 years vs <40 years; odds ratio [OR], 18.48, 95 percent CI, 2.44–140.17; p<0.001), 30-day (OR, 10.71, 2.47–46.46; p<0.001) and 1-year (OR, 17.26, 4.04–73.63; p<0.001) cardiac mortality.

The same was true for a higher Killip class upon admission (I vs IV; in-hospital: OR, 4.24, 3.11–5.77; p<0.001; 30-day: OR, 3.75, 2.79–5.05; p<0.001; 1-year: OR, 3.27, 2.50–4.27; p<0.001) and cardiac arrest upon admission (in-hospital: OR, 6.61, 4.52–9.65; p<0.001; 30-day: OR, 5.09, 3.52–7.37; p<0.001; 1-year: OR, 4.55, 3.20–6.46; p<0.001).

Elevated creatinine and troponin levels on admission, as well as the lowest left ventricular ejection fraction over the course of hospitalization, were similarly significantly predictive of in-hospital, 30-day and 1-year cardiac mortality (p<0.001 for all).

In comparison, a history of diabetes was only significantly predictive of 1-year cardiac mortality (OR, 1.33, 1.06–1.67; p=0.014), while prior ischaemic heart disease appeared to protect against in-hospital (OR, 0.55, 0.38–0.80; p=0.001) and 30-day (OR, 0.62, 0.44–0.87; p=0.006) cardiac mortality.

The obtained model was tested in the validation cohort of 3,464 patients (median age, 57.9 years; 84.5 percent female). Performance was good overall, resulting in a c-statistic of 0.922 (0.902–0.942) for in-hospital cardiac mortality. The respective values for 30-day and 1-year cardiac mortalities were 0.913 (0.891–0.935) and 0.903 (0.882–0.923).

Moreover, the model only misclassified in-hospital, 30-day and 1-year cardiac mortality cases 14.0 percent, 14.7 percent and 16.2 percent of the time, respectively.

“The potential immediate utility of these predictors is to identify those low-risk patients who could be discharged early,” said researchers. “Secondly, it could potentially be used to identify those at high risk and who would benefit from more aggressive up-titration of their prognostic medications and more frequent follow-ups.”

The obtained model could also be used when counselling patients, helping them better understand their prognoses, they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
11 Aug 2019
Treatment with low-to-standard dose dual combination therapy of blood pressure (BP)-lowering drugs is more effective than standard-dose monotherapy and does not increase withdrawals due to adverse events, a recent study has shown.
20 Jun 2019
Untreated white coat hypertension (WCH), but not treated white coat effect (WCE), may increase the risk for cardiovascular events and all-cause mortality, suggest the results of a systematic review and meta-analysis. Out-of-office blood pressure (BP) monitoring is thus important in the diagnosis and management of hypertension.
06 Aug 2019
Risk factors for 1-year mortality in heart failure (HF) patients significantly differ between those with and without chronic kidney disease (CKD), especially with regard to the use of beta-blockers or diuretics at discharge, according to a study. This suggests that these patients may benefit from individualized therapies.